Literature DB >> 33669206

Leptomeningeal Carcinomatosis of a Poorly Differentiated Cervical Carcinoma Caused by Human Papillomavirus Type 18.

Pierpaolo Zorzato1, Mattia Zambon1, Silvia Gori2, Helena Frayle2, Maria Teresa Gervasi3, Annarosa Del Mistro2.   

Abstract

Cervical cancer is caused by a persistent infection with high-risk types of Papillomaviruses (hrHPV); HPV16 and HPV18 are associated with about 70% of the cases. In the last decades the introduction of a cervical cancer screening has allowed a decrease in cervical cancer incidence and mortality; regular adhesion to the screening procedures, by pap test or HPV test, and colposcopy, according to the international guidelines, prevents cancer development and allows for diagnosis at the early stages. Nowadays, in industrialized countries, it is not common to diagnose this pathology in advanced stages, and this occurrence is frequently associated with patient's unattendance of cervical screening programs. We describe a case of delayed diagnosis of cervical cancer, posed only after the onset of the neurological symptoms caused by leptomeningeal metastases, despite a two-year history of abnormal cytology. The endocervical mass was analyzed by immunohistochemistry, and search and typing of HPV sequences was performed by PCR in the meningeal carcinomatous cells. A poorly differentiated squamous cell carcinoma was diagnosed, and HPV18 sequences were detected. This rapidly fatal case highlights the importance of following the evidence-based recommended protocols and the preventive role of the population-based cervical cancer screening programs.

Entities:  

Keywords:  HPV18; cervical cancer screening; cervical carcinoma; leptomeningeal carcinomatosis

Mesh:

Year:  2021        PMID: 33669206      PMCID: PMC7919799          DOI: 10.3390/v13020307

Source DB:  PubMed          Journal:  Viruses        ISSN: 1999-4915            Impact factor:   5.048


  24 in total

1.  Carcinoma of uterine cervix primarily presenting as carcinomatous meningitis: a case report.

Authors:  Rekha Wuntkal; Amita Maheshwari; Rajendra A Kerkar; Shubhada V Kane; Hemant B Tongaonkar
Journal:  Aust N Z J Obstet Gynaecol       Date:  2004-06       Impact factor: 2.100

2.  Leptomeningeal carcinomatosis due to squamous cell carcinoma of the uterine cervix associated with HPV-45.

Authors:  Renjitha T Ignatius; Shannon M Wills; Laura Nadeau; Mariza Deperalta-Venturina; Sheldon Weiner
Journal:  J Clin Oncol       Date:  2008-01-01       Impact factor: 44.544

3.  Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication.

Authors:  Ni Li; Silvia Franceschi; Rebecca Howell-Jones; Peter J F Snijders; Gary M Clifford
Journal:  Int J Cancer       Date:  2011-02-15       Impact factor: 7.396

Review 4.  The Pap test and Bethesda 2014.

Authors:  Ritu Nayar; David C Wilbur
Journal:  Cancer Cytopathol       Date:  2015-05-01       Impact factor: 5.284

5.  Leptomeningeal metastases from genitourinary cancer: the University of Texas MD Anderson Cancer Center experience.

Authors:  Shlomit Yust-Katz; Samuel Mathis; Morris D Groves
Journal:  Med Oncol       Date:  2013-01-05       Impact factor: 3.064

6.  hr-HPV testing in the management of women with ASC-US+ and in the follow-up of women with cytological abnormalities and negative colposcopy. Recommendations of the Italian group for cervical cancer screening (GISCi).

Authors:  Francesca Maria Carozzi; Anna Iossa; Aurora Scalisi; Mario Sideri; Karin Louise Andersson; Massimo Confortini; Annarosa Del Mistro; Giovanni Maina; Guglielmo Ronco; Patrizio Raggi; Maria Luisa Schiboni; Marco Zappa; Paolo Giorgi Rossi
Journal:  Epidemiol Prev       Date:  2015 May-Jun       Impact factor: 1.901

7.  Complete genotyping of mucosal human papillomavirus using a restriction fragment length polymorphism analysis and an original typing algorithm.

Authors:  Rui Jorge Nobre; Luís Pereira de Almeida; Teresa C Martins
Journal:  J Clin Virol       Date:  2008-03-04       Impact factor: 3.168

8.  A Meta-Analysis on Human Papillomavirus Type Distribution among Women with Cervical Neoplasia in the WHO Eastern Mediterranean Region.

Authors:  Zabihollah Shoja; Mohammad Farahmand; Neda Hosseini; Somayeh Jalilvand
Journal:  Intervirology       Date:  2019-09-17       Impact factor: 1.763

9.  The European response to the WHO call to eliminate cervical cancer as a public health problem.

Authors:  Marc Arbyn; Murat Gultekin; Philippe Morice; Pekka Nieminen; Maggie Cruickshank; Philip Poortmans; Daniel Kelly; Mario Poljak; Christine Bergeron; David Ritchie; Dietmar Schmidt; Maria Kyrgiou; Ann Van den Bruel; Laia Bruni; Partha Basu; Freddie Bray; Elisabete Weiderpass
Journal:  Int J Cancer       Date:  2020-08-04       Impact factor: 7.396

10.  Risk of high-grade lesions after atypical glandular cells in cervical screening: a population-based cohort study.

Authors:  Ingrid Norman; Anders Hjerpe; Joakim Dillner
Journal:  BMJ Open       Date:  2017-12-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.